You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A blood test to predict sudden death risk
SBC: 3PrimeDx, Inc Topic: NHLBIDESCRIPTION (provided by applicant): ROS Technologies, Inc, is a medical diagnostics company developing a blood test to predict sudden death risk in patients with heart failure (HF). Heart failure affects more than five million Americans and increases therisk of sudden death. This application sets out to develop a simple, inexpensive blood test to help predict sudden death risk that may prevent un ...
STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health -
A chimeric protein for the selective expansion of regulatory T cells
SBC: SAHANE BIOTECH INC Topic: NIAIDDESCRIPTION provided by applicant Type diabetes T D is a chronic disease caused by the autoimmune destruction of the insulin producing beta cells in the pancreas Current treatment options for T D are severely limited All patients diagnosed with T DM are placed on life long insulin therapy and the current standard of care for adult patients with T DM is intensive diabetes therapy to avoid ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A cloud based software platform to enhance reproducibility collaboration and translation of stem cell research
SBC: Cellara, LLC Topic: 400Project Summary Stem cell research has shown great potential to help treat or even cure a wide array of health conditions including cardiovascular and neurological disease cancer and diabetes This field is now beginning to move rapidly from the re search stage to clinical translation and commercial applications However it has been widely recognized that stem cell scientists have difficulty ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Additively Manufactured Insulated Throat Insert (AMITI)
SBC: Exo-Atmospheric Technologies LLC Topic: MDA21T005In Phase I, Exo-Atmospheric Technologies, LLC (EXO) and their research partner Purdue University (Purdue) will fabricate two additively manufactured (AM) throat inserts, optimized for thermal insulation and structural performance using Topology Optimization, that are to be filled and consolidated with a high temperature ceramic. The assembly will undergo a hot isostatic press (HIP) procedure at Ex ...
STTR Phase I 2022 Department of DefenseMissile Defense Agency -
A digital brain-gut therapy platform for enhanced management of Irritable Bowel Syndrome
SBC: METAME HEALTH,INC Topic: RProject Summary Abstract Irritable Bowel Syndrome IBS is a chronic and costly digestive condition characterized by abdominal pain and altered bowel habits diarrhea constipation or mixed type IBS is a disorder of brain gut dysregulation including the amplification of normal gut signals at the level of the brain Yet most medical therapies for IBS to date have focused on symptom management and dietar ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Adjustable prosthetic sockets for children and adolescents with lower limb loss to accommodate growth
SBC: IFIT PROSTHETICS, LLC Topic: NICHDPediatric limb loss, although relatively infrequent compared to adults, results in substantial hardship for children and their families. The principal business interest― iFIT Prosthetics, LLC®― successfully developed and manufactured innovative, fully adjustable, transtibial and transfemoral prosthetic devices, and demonstrated their safety, comfort, and functionality in adults. Made of injec ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Adjustable prosthetic sockets for children and adolescents with lower limb loss to accommodate growth
SBC: IFIT PROSTHETICS, LLC Topic: NICHDPediatric limb loss, although relatively infrequent compared to adults, results in substantial hardship for children and their families. The principal business interest? iFIT Prosthetics, LLC®? successfully developed and manufactured innovative, fully adjustable, transtibial and transfemoral prosthetic devices, and demonstrated their safety, comfort, and functionality in adults. Made of injection ...
STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health -
Advanced Multi-Modal Wearable Sensing for the Prediction of Pre-Term Labor
SBC: Sonica LLC Topic: NICHDPreterm birthPTBdelivery prior toweeks gestational ageaccounts forof all births and remains the leading cause of neonatal deathThe majority of PTB is preceded by spontaneous preterm laborPTLCurrentlythere is a major unmet need for methods to identify women at risk of PTL and provide an early warning system for potential interventionhome uterine monitoringHUMis one approach that has shown some prom ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Advanced Quantitative Magnetic Resonance Imaging Phantoms for Nonalcoholic Fatty Liver Disease
SBC: CALIMETRIX LLC Topic: NIBIBPROJECT SUMMARYThe overall goal of this Phase I proposal is to design and test the feasibility of novel magnetic resonance imaging (MRI) reference standards (“phantoms”) that are urgently needed for comprehensive and standardized quality assurance (QA) of quantitative MRI biomarkers of non-alcoholic fatty liver disease (NAFLD). We propose to develop 1) a quantitative MR elastography (MRE) stif ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
A Force-controlled Probe Based Platform for Single Cell Biomolecular Delivery
SBC: INFINITESIMAL, LLC Topic: NIGMSDESCRIPTION (provided by applicant): Application of nanotechnology in medicine, nanomedicine, has provided numerous emerging opportunities in healthcare, particularly given ever increasing demand for in vitro toxicology and diagnostics towards personalized medicine. With increasing demand for personalized medicine, pharmaceutical companies strive in taking advantage of the potential of nan ...
STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health